Early Postnatal Growth in Bronchopulmonary Dysplasia 228
نویسندگان
چکیده
منابع مشابه
Postnatal Growth in Preterms with Bronchopulmonary Dysplasia.
Aim of study - to measure growth data for 69 preterms (39 females) with bronchopulmonary dysplasia (PT-BPD) The growth parameters of 69 BPD-PT were recorded for 16±3 months postnatally. 40 had mild, 20 had moderate and 9 had severe BPD. Ninety-six percent of infants were appropriate for gestational age (AGA). Only 4% preterms had birth weight SDS <-2 for gestational age (GA) and 4% had length S...
متن کاملBronchopulmonary dysplasia and postnatal growth in extremely premature black infants.
Bronchopulmonary dysplasia (BPD) may adversely affect the postnatal growth of the extremely premature infant; however, most studies have not controlled for birth weight. We studied 90 Black premature infants (mean birth weight 989 +/- 148 g). Weight was recorded biweekly until discharge and at 4, 8, and 12 months of age corrected for prematurity. Infants with BPD (N = 23) were contrasted with i...
متن کاملBronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.
ary dysplasia.2 The incidence of bronchopulmonary dysplasia among ventilated infants varies, depending on gestational age, from 4-2% to as high as 40%,'1 4 but increases up to 70% among infants in whom it is necessary to prolong mechanical ventilation beyond two weeks.5 Such infants have an increased mortality and morbidity even after discharge from neonatal intensive care. Readmission is commo...
متن کاملPolicy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insuffic...
متن کاملPolicy Statement—Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insuffic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1996
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199609000-00251